DK385777A - Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf - Google Patents

Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf

Info

Publication number
DK385777A
DK385777A DK385777A DK385777A DK385777A DK 385777 A DK385777 A DK 385777A DK 385777 A DK385777 A DK 385777A DK 385777 A DK385777 A DK 385777A DK 385777 A DK385777 A DK 385777A
Authority
DK
Denmark
Prior art keywords
salts
procedure
preparation
cephalosporine derivatives
cephalosporine
Prior art date
Application number
DK385777A
Other languages
English (en)
Other versions
DK151340C (da
DK151340B (da
Inventor
K Naito
K Tsukamura
H Sinbo
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK385777A publication Critical patent/DK385777A/da
Publication of DK151340B publication Critical patent/DK151340B/da
Application granted granted Critical
Publication of DK151340C publication Critical patent/DK151340C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK385777A 1976-08-31 1977-08-30 Analogifremgangsmaade til fremstilling af et krystallinsk cephalosporinderivat DK151340C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10458376 1976-08-31
JP51104583A JPS603314B2 (ja) 1976-08-31 1976-08-31 セフアロスポリン誘導体およびその製造法

Publications (3)

Publication Number Publication Date
DK385777A true DK385777A (da) 1978-03-01
DK151340B DK151340B (da) 1987-11-23
DK151340C DK151340C (da) 1988-04-25

Family

ID=14384446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK385777A DK151340C (da) 1976-08-31 1977-08-30 Analogifremgangsmaade til fremstilling af et krystallinsk cephalosporinderivat

Country Status (15)

Country Link
US (1) US4146710A (da)
JP (1) JPS603314B2 (da)
BE (1) BE858296A (da)
BG (1) BG60439B2 (da)
CA (1) CA1102310A (da)
CH (1) CH630088A5 (da)
DE (1) DE2738711C2 (da)
DK (1) DK151340C (da)
FR (1) FR2364922A1 (da)
GB (1) GB1589841A (da)
HK (1) HK27784A (da)
MY (1) MY8500266A (da)
NL (1) NL189355C (da)
NO (1) NO154015C (da)
SE (1) SE426069B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575803A (en) * 1976-03-09 1980-10-01 Fujisawa Pharmaceutical Co 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
US4189479A (en) * 1977-12-22 1980-02-19 Takeda Chemical Industries, Ltd. Cephalosporin esters
US4180658A (en) * 1978-02-24 1979-12-25 Bristol-Myers Company 7[-2-Alkoxyamino(acetamido)]cephalosporin derivatives
JPS5579393A (en) * 1978-12-11 1980-06-14 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
JPS58189186A (ja) * 1982-04-30 1983-11-04 Takeda Chem Ind Ltd セフアロスポリン誘導体
JPS63266177A (ja) * 1987-04-22 1988-11-02 Toyota Autom Loom Works Ltd 揺動斜板型圧縮機におけるコンロツドの連結方法
JPH06122630A (ja) * 1992-10-12 1994-05-06 Taiyo Yakuhin Kogyo Kk 安定な塩酸セフォチアム製剤
GB9503717D0 (en) * 1995-02-24 1995-04-12 Smithkline Beecham Plc Novel compounds
CN103601737B (zh) * 2013-12-04 2016-02-03 哈药集团制药总厂 一种盐酸头孢替安的制备方法
CN104926835B (zh) * 2015-06-24 2017-10-03 山东罗欣药业集团股份有限公司 一种盐酸头孢替安化合物、其制备方法及其药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho

Also Published As

Publication number Publication date
DE2738711C2 (de) 1985-07-11
JPS603314B2 (ja) 1985-01-26
DE2738711A1 (de) 1978-03-02
DK151340C (da) 1988-04-25
US4146710A (en) 1979-03-27
NO772960L (no) 1978-03-01
CH630088A5 (de) 1982-05-28
FR2364922A1 (fr) 1978-04-14
JPS5329913A (en) 1978-03-20
BG60439B2 (bg) 1995-03-31
NL7709614A (nl) 1978-03-02
HK27784A (en) 1984-03-30
GB1589841A (en) 1981-05-20
BE858296A (fr) 1978-02-28
FR2364922B1 (da) 1981-07-31
SE7709745L (sv) 1978-03-01
SE426069B (sv) 1982-12-06
MY8500266A (en) 1985-12-31
NL189355C (nl) 1993-03-16
DK151340B (da) 1987-11-23
NO154015B (no) 1986-03-24
CA1102310A (en) 1981-06-02
NO154015C (no) 1986-07-02
NL189355B (nl) 1992-10-16

Similar Documents

Publication Publication Date Title
DK499778A (da) Fremgangsmaade til fremstilling af 9-(omegaheteroarylamino-alkylamino)-erythromyciner eller salte deraf
DK142372C (da) Fremgangsmaade til fremstilling af androstan-17-on-derivater
DK358980A (da) Fremgangsmaade til fremstilling af salte af (+)-katekin
DK148260C (da) Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf
DK154289C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK5976A (da) Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf
DK273479A (da) Fremgangsmaade til fremstilling af 5-phenylpyrazol-forbindelser eller salte deraf
DK27078A (da) Fremgangsmaade til fremstilling af imidazoquinoliner eller salte deraf
DK209176A (da) Fremgangsmade til fremstilling af n-substituerede phenylpiperidinderivater eller salte deraf
DK385777A (da) Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK511878A (da) Fremgangsmaade til fremstilling af imidazobenzoazepiner eller salte deraf
DK223177A (da) Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf
DK58677A (da) Fremgangsmade til fremstilling af m-trifluormethylphenylpiperidinderivater eller additionssalte deraf
DK147623C (da) Analogifremgangsmaade til fremstilling af azapurinderivater eller salte deraf
DK154970C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK338376A (da) Fremgangsmade til fremstilling af aminobenzocycloheptenderivater eller additionssalte deraf
DK118177A (da) Fremgangsmade til fremstilling af isobutyramidderivater
DK127676A (da) Fremgangsmade til fremstilling af 9-alkylamino-erythromyciner eller salte deraf
DK232677A (da) Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK528777A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK115379A (da) Fremgangsmaade til fremstilling af dilignoler eller dilignollignende forbindelser eller salte heraf

Legal Events

Date Code Title Description
PUP Patent expired